116 related articles for article (PubMed ID: 16932026)
21. Do Orthopaedic Oncologists Agree on the Diagnosis and Treatment of Cartilage Tumors of the Appendicular Skeleton?
Zamora T; Urrutia J; Schweitzer D; Amenabar PP; Botello E
Clin Orthop Relat Res; 2017 Sep; 475(9):2176-2186. PubMed ID: 28205076
[TBL] [Abstract][Full Text] [Related]
22. Expression of insulin-like growth factor II mRNA binding protein 3 (IMP3) in enchondroma and chondrosarcoma.
Shooshtarizadeh T; Nazeri A; Zare-Mirzaie A; Movahedinia S
Pathol Res Pract; 2016 Apr; 212(4):335-9. PubMed ID: 26948096
[TBL] [Abstract][Full Text] [Related]
23. Imaging of chondrosarcoma with histopathological and prognostic correlation. An analysis of 49 cases mainly based on plain film radiography.
Jurik AG; Jensen O; Keller J; Nielsen OS; Lundorf E; Daugaard S; Sneppen O
Rofo; 1995 Nov; 163(5):372-7. PubMed ID: 8527748
[TBL] [Abstract][Full Text] [Related]
24. [Dedifferentiated chondrosarcoma: radiologic-pathologic correlation].
Bierry G; Feydy A; Larousserie F; Pluot E; Guerini H; Campagna R; Dufau-Andreu C; Anract P; Babinet A; Dietemann JL; Chevrot A; Drapé JL
J Radiol; 2010 Mar; 91(3 Pt 1):271-9. PubMed ID: 20508557
[TBL] [Abstract][Full Text] [Related]
25. Cartilage-forming tumors.
Qasem SA; DeYoung BR
Semin Diagn Pathol; 2014 Jan; 31(1):10-20. PubMed ID: 24680178
[TBL] [Abstract][Full Text] [Related]
26. Cartilage tumors: evaluation and treatment.
Marco RA; Gitelis S; Brebach GT; Healey JH
J Am Acad Orthop Surg; 2000; 8(5):292-304. PubMed ID: 11029557
[TBL] [Abstract][Full Text] [Related]
27. Biomarkers of chondrosarcoma.
Jeong W; Kim HJ
J Clin Pathol; 2018 Jul; 71(7):579-583. PubMed ID: 29593061
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic imaging of malignant cartilage tumors.
Masciocchi C; Sparvoli L; Barile A
Eur J Radiol; 1998 May; 27 Suppl 1():S86-90. PubMed ID: 9652507
[TBL] [Abstract][Full Text] [Related]
29. Prognostic factors and outcome of pelvic, sacral, and spinal chondrosarcomas: a center-based study of 69 cases.
Bergh P; Gunterberg B; Meis-Kindblom JM; Kindblom LG
Cancer; 2001 Apr; 91(7):1201-12. PubMed ID: 11283918
[TBL] [Abstract][Full Text] [Related]
30. Dedifferentiated chondrosarcoma revisited.
Mavrogenis AF; Ruggieri P; Mercuri M; Papagelopoulos PJ
J Surg Orthop Adv; 2011; 20(2):106-11. PubMed ID: 21838071
[TBL] [Abstract][Full Text] [Related]
31. Does local recurrence impact survival in low-grade chondrosarcoma of the long bones?
Schwab JH; Wenger D; Unni K; Sim FH
Clin Orthop Relat Res; 2007 Sep; 462():175-80. PubMed ID: 17514007
[TBL] [Abstract][Full Text] [Related]
32. Chondrosarcoma of the hyoid bone: a case report.
Ciolofan MS; Ioniţă E; Ioniţă I; Mogoantă CA; Anghelina F; Enescu AŞ; Ciobîrcă DM; Osman A; Foarfă MC; Mateescu GO
Rom J Morphol Embryol; 2015; 56(2 Suppl):811-6. PubMed ID: 26429177
[TBL] [Abstract][Full Text] [Related]
33. Expression of molecular markers in low-grade chondrosarcomas and cartilaginous tumors with uncertain differentiation.
Boulytcheva IV; Kushlinskii NE; Soloviev YN; Aliev MD
Klin Lab Diagn; 2013 Oct; (10):61-3, 25-30. PubMed ID: 24640098
[TBL] [Abstract][Full Text] [Related]
34. Chondroid chordomas and low-grade chondrosarcomas of the craniospinal axis. An immunohistochemical analysis of 17 cases.
Wojno KJ; Hruban RH; Garin-Chesa P; Huvos AG
Am J Surg Pathol; 1992 Dec; 16(12):1144-52. PubMed ID: 1463093
[TBL] [Abstract][Full Text] [Related]
35. Interobserver reliability in the histopathological diagnosis of cartilaginous tumors in patients with multiple osteochondromas.
de Andrea CE; Kroon HM; Wolterbeek R; Romeo S; Rosenberg AE; De Young BR; Liegl B; Inwards CY; Hauben E; McCarthy EF; Idoate M; Athanasou NA; Jones KB; Hogendoorn PC; Bovée JV
Mod Pathol; 2012 Sep; 25(9):1275-83. PubMed ID: 22555180
[TBL] [Abstract][Full Text] [Related]
36. Expression of p53 protein and Ki-67 antigen in phyllodes tumor of the breast.
Chan YJ; Chen BF; Chang CL; Yang TL; Fan CC
J Chin Med Assoc; 2004 Jan; 67(1):3-8. PubMed ID: 15077883
[TBL] [Abstract][Full Text] [Related]
37. Assessment of interobserver variability and histologic parameters to improve reliability in classification and grading of central cartilaginous tumors.
Eefting D; Schrage YM; Geirnaerdt MJ; Le Cessie S; Taminiau AH; Bovée JV; Hogendoorn PC;
Am J Surg Pathol; 2009 Jan; 33(1):50-7. PubMed ID: 18852676
[TBL] [Abstract][Full Text] [Related]
38. Reduced expression of von Hippel-Lindau protein correlates with decreased apoptosis and high chondrosarcoma grade.
Chen C; Zhou H; Liu X; Liu Z; Ma Q
J Bone Joint Surg Am; 2011 Oct; 93(19):1833-40. PubMed ID: 22005870
[TBL] [Abstract][Full Text] [Related]
39. Clear cell chondrosarcoma of bone: long time follow-up of 18 cases.
Donati D; Yin JQ; Colangeli M; Colangeli S; Bella CD; Bacchini P; Bertoni F
Arch Orthop Trauma Surg; 2008 Feb; 128(2):137-42. PubMed ID: 17522879
[TBL] [Abstract][Full Text] [Related]
40. Metastatic Potential of Grade I Chondrosarcoma of Bone: Results of a Multi-institutional Study.
Andreou D; Gilg MM; Gosheger G; Werner M; Hardes J; Pink D; Leithner A; Tunn PU; Streitbürger A
Ann Surg Oncol; 2016 Jan; 23(1):120-5. PubMed ID: 26350369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
